P3 Health Partners Inc [NASDAQ: PIII] surged by $0.03 during the normal trading session on while it closed the day at $0.50.
P3 Health Partners Inc stock has also gained 2.21% of its value over the past 7 days. However, PIII stock has inclined by 3.43% in the 3 months of the year. Over the past six months meanwhile, it has lost -51.54% and lost -64.26% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for PIII stock reached $81.53 million, with 116.59 million shares outstanding and 87.98 million shares in the current float. Compared to the average trading volume of 304.90K shares, PIII reached a trading volume of 2814631 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about P3 Health Partners Inc [PIII]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PIII shares is $2.47 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PIII stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for P3 Health Partners Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 01, 2024. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on September 01, 2023, representing the official price target for P3 Health Partners Inc stock.
The Average True Range (ATR) for P3 Health Partners Inc is set at 0.05, with the Price to Sales ratio for PIII stock in the period of the last 12 months amounting to 0.06. The Price to Book ratio for the last quarter was 0.49, with the Price to Cash per share for the same quarter was set at 0.48.
PIII stock trade performance evaluation
P3 Health Partners Inc [PIII] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.21. With this latest performance, PIII shares dropped by -20.00% in over the last four-week period, additionally sinking by -51.54% over the last 6 months – not to mention a drop of -71.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PIII stock in for the last two-week period is set at 41.20, with the RSI for the last a single of trading hit 40.17, and the three-weeks RSI is set at 42.92 for P3 Health Partners Inc [PIII]. The present Moving Average for the last 50 days of trading for this stock 0.5558, while it was recorded at 0.4961 for the last single week of trading, and 0.8465 for the last 200 days.
P3 Health Partners Inc [PIII]: An insightful look at the core fundamentals
P3 Health Partners Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.69 and a Current Ratio set at 0.69.
Earnings per share (EPS) analysis for P3 Health Partners Inc [PIII] stock
With the latest financial reports released by the company, P3 Health Partners Inc posted -0.12/share EPS, while the average EPS was predicted by analysts to be reported at -0.22/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.1. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PIII.
P3 Health Partners Inc [PIII]: Institutional Ownership
There are presently around $23.65%, or 30.86%% of PIII stock, in the hands of institutional investors. The top three institutional holders of PIII stocks are: ALYESKA INVESTMENT GROUP, L.P. with ownership of 15.95 million shares, which is approximately 13.4152%. ARMISTICE CAPITAL, LLC, holding 7.9 million shares of the stock with an approximate value of $$3.56 million in PIII stocks shares; and ARMISTICE CAPITAL, LLC, currently with $$2.85 million in PIII stock with ownership which is approximately 5.3228%.
